Skip to main content

Nonprofit company vows to produce generic insulin and sell it for $1 a day

Success is far from guaranteed, given that the established players all have a strong financial interest in seeing Civica’s efforts fail.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.